The case for & against
Bull & Bear analysis
Covista, Inc. (NASDAQ: CVSA) operates as a leading provider in healthcare workforce development, connecting educational institutions with employers to produce qualified healthcare professionals. The company is focused on alleviating the staffing shortages in the U.S. healthcare sector, addressing approximately 700,000 job openings against 306,000 unemployed healthcare workers. Covista has positioned itself well by launching innovative educational programs and leveraging partnerships to enhance clinician support and mental health resources, reflecting its commitment to addressing current workforce challenges.
Bull says
- ↑Revenue rose 4.5% YoY to $487 M; FY26 revenue guidance at $1.93–1.945 B.
- ↑Adjusted EPS expected to grow 19–22% YoY, boosting margins.
- ↑Free cash flow up 17% YoY to $336 M; repurchased $66 M in shares.
- ↑Total enrollment +6.8%, 11th straight growth quarter; launched 1,400-student programs.
- ↑Well-positioned amid 700K monthly healthcare job openings; campus expansion active.
- ↑Qualitative factors: strong earnings yield, positive revisions, solid profitability, low volatility.
Bear says
- ↓Stock trades ~25% above intrinsic value: $135.55 vs $108.36 fair estimate.
- ↓Executives sold $719K shares recently, signaling potential confidence weakness.
- ↓New campus developments face regulatory delays, slowing expansion.
- ↓Intensifying competition in healthcare education could erode market share.
- ↓Revenue highly dependent on enrollment trends; any slowdown risks topline.
- ↓High leverage risk, no dividend returns, and weak institutional ownership.
Investment themes with CVSA
Everyday goods and personal services for consumers
Top stock picks curated by Seeking Alpha
Earnings Call · Q3 2026 · Mgmt. Guidance
Transcript signals
Bull points
- Chamberlain occupies an enviable position in nursing education with incredible brand equity that resonates with both students and employers alike.
- We delivered strong financial performance, raised our revenue outlook, and for the second straight quarter, raised our adjusted earnings per share guidance.
- revenue in the third quarter increased 4.5% to $487 million, driven by enrollment growth across all three segments.
Bear points
- What I would tell you is that I would expect the fourth quarter to ramp up further from where we were in the third quarter.